Home    Back

Helium / oxygen mixed gas inhalation therapy    (DrugBank: Oxygen, Helium)

3 diseases
IDDisease name (Link within this page)Number of trials
228Bronchiolitis obliterans0
299Cystic fibrosis0
330Congenital tracheal stenosis / Congenital subglottic stenosis [Congenital tracheal stenosis (~Mar 2018)]1

228. Bronchiolitis obliterans    [ 92 clinical trials,   125 drugs,   (DrugBank: 34 drugs),   33 drug target genes,   152 drug target pathways]
Searched query = "Bronchiolitis obliterans", "Obliterating bronchiolitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 92 trial found

299. Cystic fibrosis    [ 1,592 clinical trials,   1,539 drugs,   (DrugBank: 255 drugs),   81 drug target genes,   162 drug target pathways]
Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 1,592 trial found

330. Congenital tracheal stenosis / Congenital subglottic stenosis [Congenital tracheal stenosis (~Mar 2018)]    [ 1 clinical trial,   3 drugs,   (DrugBank: 2 drugs),   0 drug target gene,   0 drug target pathway]
Searched query = "Congenital tracheal stenosis / Congenital subglottic stenosis [Congenital tracheal stenosis (~Mar 2018)]", "Congenital tracheal stenosis", "Congenital subglottic stenosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 1 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1JPRN-JMA-IIA00357
01/07/201819/06/2018Phase II trial of helium / oxygen mixed gas for respiratory failure secondary to airway obstructive lesion in childrenPhase II trial of helium / oxygen mixed gas for respiratory failure secondary to airway obstructive lesion in children Respiratory failure due to airway obstructive lesion such as acute bronchiolitis, congenital tracheal stenosis, bronchial asthma attackIntervention type:DRUG. Intervention1:Helium / oxygen mixed gas inhalation therapy, Dose form:INSUFFLATION, Route of administration:INHALATIONAL, intended dose regimen:Helium / oxygen mixed gas .Tokyo Metropolitan Children's Medical CenterNational Center for Child Health and DevelopmentRecruitingNo Limit<20 YEARSBOTH15Phase 2Japan